Skip to main content
Loading

Opening Address & Keynote Presentation: Rethinking the Oligonucleotide Backbone: A New Approach to RNA Therapeutic Design

30 Apr 2026
Novel Modalities & Discovery Drug Delivery CMC & Process Development Quality Control
Opening Address & Keynote Presentation: Rethinking the Oligonucleotide Backbone: A New Approach to RNA Therapeutic Design
Industry Expert
David R. Tabatadze, President & CEO - ZATA Pharmaceuticals